Bio Access Platforms
↗Palo Alto, California, USA
Bio Access Platforms is an AI-powered software company providing predictive analytics tools specifically designed for pharmaceutical market access and commercialization. The company's platform integrates AI-driven revenue forecasting, patient flow modeling, and contract automation to help life sciences companies optimize global drug launches and manage complex revenue streams.
Their core products, 'Drug Revenue Forecaster' and 'Drug Contract Pulse,' enable pharma and biotech teams to significantly reduce the costs and manual effort associated with forecasting while improving accuracy in under-resourced or complex global markets. By leveraging machine learning, the platform allows for real-time scenario analysis and streamlined contract management, bridging the gap between clinical development and commercial success.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Pharma Software & Market Access
SIZE & FINANCIALS
Employees:1-50
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Accelerator/Incubator (unspecified)
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Software Platform)
Modalities:Small molecule, Biologics, Cell & Gene Therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:PharmaCCX (Founder connection), Various mid-to-large cap biotech firms for pilot programs
COMPETITION
Position:Emerging
Competitors:Claritas Rx, Model N, IntegriChain, Veeva Systems (Market Access modules), Prospection
LEADERSHIP
Key Executives:
Armen Solakhyan - Founder & CEO
Sonja Nakasian - Chief Science and Strategy Officer
Paul Richardson - Chief Commercial Officer
Scientific Founders:Armen Solakhyan, Sonja Nakasian
LINKS
Website:bioaccessplatforms.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bio Access Platforms. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.